Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Monopar Therapeutics Inc
(NQ:
MNPR
)
6.785
+0.945 (+16.17%)
Streaming Delayed Price
Updated: 10:33 AM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
756,646
Open
6.200
Bid (Size)
6.680 (26)
Ask (Size)
6.790 (2)
Prev. Close
5.840
Today's Range
6.100 - 7.100
52wk Range
1.369 - 8.650
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Monopar Therapeutics (MNPR) Stock Is Skyrocketing Today
September 12, 2024
Monopar Therapeutics shares are trading higher by 108% Thursday morning. The company announced early Phase 1 trial data confirming MNPR-101-Zr's tumor-targeting ability in humans.
Via
Benzinga
Monopar Announces Positive Early Human Clinical Data Validating the Tumor Targeting Ability of MNPR-101-Zr
September 12, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Performance
YTD
+266.74%
+266.74%
1 Month
+182.69%
+182.69%
3 Month
+82.75%
+82.75%
6 Month
+99.25%
+99.25%
1 Year
+138.01%
+138.01%
More News
Read More
Monopar to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
September 04, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Regains Compliance with Nasdaq Minimum Bid Price Rule
August 27, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Receives Clearance to Proceed with Phase 1 Therapeutic Trial of Novel Radiopharmaceutical in Advanced Cancers
August 21, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Announces Initial Data for First Patient Dosed in Radiopharma Phase 1 Clinical Trial of MNPR-101-Zr
August 14, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
MNPR Stock Earnings: Monopar Therapeutics Misses EPS for Q2 2024
August 09, 2024
Via
InvestorPlace
Monopar Therapeutics Reports Second Quarter 2024 Financial Results and Recent Developments
August 09, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Therapeutics Announces 1-for-5 Reverse Stock Split
August 09, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Announces First Patient Enrolled in First-in-Human Phase 1 Trial for Its Novel Radiopharmaceutical MNPR-101-Zr
July 09, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Announces MNPR-101-RIT Abstract Accepted as a Top-Rated Oral Presentation at EANM’24
June 25, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying
June 24, 2024
Via
Benzinga
Monopar and NorthStar Amend & Extend Collaboration
June 11, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Presents Data Showcasing the Appeal of uPAR as a Radiopharma Cancer Target and of its lead Clinical Program at the 2024 SNMMI Annual Meeting
June 10, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 07, 2024
Via
Benzinga
Penny Stocks That Insiders Are Loading Up On: 3 Names to Watch Closely
June 05, 2024
Via
InvestorPlace
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Monopar Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying
June 03, 2024
Via
Benzinga
Monopar Announces CFO Succession
May 24, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
May 09, 2024
Via
Benzinga
MNPR Stock Earnings: Monopar Therapeutics Beats EPS for Q1 2024
May 09, 2024
Via
InvestorPlace
Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline
May 09, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
May 03, 2024
Via
Benzinga
Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting
April 18, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings
April 16, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients
April 10, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.